HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Miyamoto Selected Research

Biomarkers (Surrogate Marker)

1/2024Asian flush is a potential protective factor against COVID-19: a web-based retrospective survey in Japan.
1/2024A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
7/2023Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives.
11/2022Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.
7/2022Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives.
5/2022miR-144-3p/miR-451a promotes lymphovascular invasion through repression of PTEN/p19 in rectal neuroendocrine tumors.
10/2020The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma.
1/2020MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
10/2017Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.
3/2017Downregulation of microRNA-100/microRNA-125b is associated with lymph node metastasis in early colorectal cancer with submucosal invasion.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Miyamoto Research Topics

Disease

140Neoplasms (Cancer)
04/2024 - 05/2003
70Prostatic Neoplasms (Prostate Cancer)
05/2024 - 02/2002
67Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 04/2007
34Stomach Neoplasms (Stomach Cancer)
07/2023 - 12/2012
30Carcinogenesis
01/2023 - 01/2009
24Carcinoma (Carcinomatosis)
03/2024 - 03/2007
19Infections
01/2024 - 03/2003
16Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 01/2012
16Neoplasm Metastasis (Metastasis)
05/2022 - 01/2009
14Hepatocellular Carcinoma (Hepatoma)
10/2023 - 02/2016
11Margins of Excision
12/2023 - 08/2013
10Disease Progression
01/2024 - 01/2004
9Adenocarcinoma
01/2022 - 01/2009
8Lymphatic Metastasis
01/2024 - 03/2016
5Polyps
12/2022 - 06/2017
5Adenoma (Adenomas)
12/2022 - 03/2018
5Esophageal Neoplasms (Esophageal Cancer)
03/2020 - 05/2018
5Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2020 - 09/2003
4Kyphosis
10/2023 - 11/2009
4Necrosis
03/2023 - 01/2018
4Pancreatic Neoplasms (Pancreatic Cancer)
08/2020 - 12/2013
4Ascites
01/2018 - 12/2012
3Esophageal Squamous Cell Carcinoma
02/2024 - 11/2022
3Virus Diseases (Viral Diseases)
01/2024 - 01/2020
3Sarcoidosis (Schaumann Disease)
01/2023 - 04/2009
3Inflammation (Inflammations)
11/2021 - 10/2017
3Bone Resorption
01/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

59Androgen Receptors (Androgen Receptor)IBA
03/2024 - 02/2002
43AndrogensIBA
01/2024 - 04/2003
26Proteins (Proteins, Gene)FDA Link
11/2022 - 09/2003
24Biomarkers (Surrogate Marker)IBA
01/2024 - 09/2008
22Cisplatin (Platino)FDA LinkGeneric
12/2023 - 03/2013
18Hormones (Hormone)IBA
04/2024 - 04/2003
17Prostate-Specific Antigen (Semenogelase)IBA
10/2022 - 04/2003
15Small Interfering RNA (siRNA)IBA
01/2024 - 04/2007
14Messenger RNA (mRNA)IBA
12/2022 - 09/2003
14Estrogen ReceptorsIBA
11/2021 - 11/2012
13Docetaxel (Taxotere)FDA Link
01/2020 - 03/2013
11Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2023 - 12/2012
10SteroidsIBA
03/2024 - 12/2005
10CarcinogensIBA
01/2023 - 04/2008
8LigandsIBA
01/2024 - 01/2012
8Transcription Factors (Transcription Factor)IBA
01/2020 - 09/2011
8Androgen Antagonists (Antiandrogens)IBA
10/2016 - 04/2003
7SilverIBA
11/2023 - 01/2014
7lenvatinibIBA
10/2023 - 06/2020
7Dihydrotestosterone (Androstanolone)IBA
01/2020 - 12/2005
6GemcitabineFDA Link
12/2023 - 01/2015
6Durapatite (Hydroxylapatite)IBA
11/2023 - 08/2013
6DNA (Deoxyribonucleic Acid)IBA
09/2023 - 01/2012
6CytokinesIBA
11/2021 - 01/2012
6Gonadal Steroid Hormones (Sex Hormones)IBA
11/2021 - 01/2014
6Sorafenib (BAY 43-9006)FDA Link
09/2021 - 02/2016
6ErbB Receptors (EGF Receptor)IBA
06/2019 - 08/2011
6Anti-Bacterial Agents (Antibiotics)IBA
03/2011 - 02/2003
5AlbuminsIBA
01/2023 - 01/2011
5Estrogens (Estrogen)FDA Link
01/2020 - 01/2014
5hydroxyflutamideIBA
01/2020 - 08/2011
5silodosinFDA Link
01/2020 - 06/2013
5GlucocorticoidsIBA
12/2019 - 12/2012
5C-Reactive ProteinIBA
12/2019 - 11/2006
5Interleukin-6 (Interleukin 6)IBA
01/2018 - 05/2004
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2024 - 11/2002
4AntibodiesIBA
06/2023 - 01/2004
4Calcibiotic Root Canal SealerIBA
12/2022 - 01/2017
4EnzymesIBA
07/2022 - 02/2013
4Cetuximab (Erbitux)FDA Link
11/2020 - 01/2012
4Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2020 - 06/2014
4Flutamide (Eulexin)FDA LinkGeneric
01/2020 - 04/2007
4Prednisone (Sone)FDA LinkGeneric
01/2020 - 08/2014
4Dexamethasone (Maxidex)FDA LinkGeneric
12/2018 - 12/2012
3LeptinIBA
04/2024 - 08/2016
3AdiponectinIBA
04/2024 - 08/2016
3AdipokinesIBA
04/2024 - 08/2016
3Immune Checkpoint InhibitorsIBA
03/2024 - 01/2023
3Bevacizumab (Avastin)FDA Link
10/2023 - 11/2020
3MethylcholanthreneIBA
01/2023 - 02/2016
3AzoxymethaneIBA
12/2022 - 10/2013
3Therapeutic UsesIBA
07/2022 - 04/2008
3Progesterone Receptors (Progesterone Receptor)IBA
08/2020 - 11/2016
3enzalutamideIBA
12/2019 - 10/2016

Therapy/Procedure

61Therapeutics
03/2024 - 04/2003
35Drug Therapy (Chemotherapy)
12/2023 - 09/2008
32Prostatectomy (Retropubic Prostatectomy)
05/2024 - 11/2009
11Radiotherapy
06/2023 - 09/2008
10Gastrectomy
11/2021 - 07/2007
10Cystectomy
09/2021 - 04/2010
9Castration
09/2023 - 09/2005
7Neoadjuvant Therapy
07/2022 - 01/2015
5Chemoprevention
11/2023 - 10/2013
5Conservative Treatment
10/2023 - 11/2005
5Combination Drug Therapy (Combination Chemotherapy)
01/2019 - 03/2013
4Chemoradiotherapy
02/2024 - 05/2018
4Laminoplasty
02/2023 - 04/2009
4Aftercare (After-Treatment)
01/2023 - 04/2009
4Immunotherapy
01/2023 - 01/2020
4Nephrectomy
09/2021 - 12/2013
3Orchiectomy (Orchidectomy)
09/2021 - 08/2011
3Pedicle Screws
07/2021 - 12/2009
3Esophagectomy
10/2020 - 06/2019